TABLE 2.

The correlation between METTL14 and chemokines in ccRCC.

Correlated gene	Spearman’s correlation	Pearson’s correlation	p-value	q-value
CCL5	−0.43	−0.41	1.67E-17	1.02E-16
CCL17	−0.34	−0.36	9.98E-11	3.61E-10
CXCL13	−0.34	−0.27	3.69E-11	1.38E-10
CXCL1	−0.28	−0.26	7.34E-08	2.07E-07
CXCL16	−0.28	−-0.20	1.06E-07	2.96E-07
CCL19	−0.28	−0.29	1.07E-07	2.99E-07
CCL26	−0.27	−0.34	1.64E-07	4.48E-07
CCL25	−0.27	−0.22	4.35E-07	1.15E-06
CCL20	−0.23	−0.21	1.69E-05	3.81E-05
CCL11	−0.22	−0.23	2.77E-05	6.11E-05
CXCL2	−0.22	−0.02	2.79E-05	6.14E-05
CXCL5	−0.21	−0.17	5.42E-05	1.16E-04
CXCL6	−0.20	−0.14	1.65E-04	3.32E-04
CCL15	−0.20	−0.11	1.93E-04	3.86E-04
CCL21	−0.19	−0.19	2.35E-04	4.66E-04
CXCL14	−0.19	−0.14	3.60E-04	7.00E-04
CCL23	−0.19	−0.17	4.49E-04	8.63E-04
CXCL4	−0.18	−0.14	7.51E-04	1.41E-03
CCL4	−0.17	−0.13	1.23E-03	2.24E-03
CCL3	−0.16	−0.16	2.04E-03	3.60E-03
CXCL3	−0.13	−0.07	1.72E-02	2.65E-02
CXCL8	−0.12	−0.05	2.64E-02	3.93E-02
CCL22	−0.10	−0.06	5.80E-02	8.14E-02
CCL18	−0.10	−0.08	6.59E-02	9.14E-02
CCL13	−0.09	−0.10	7.95E-02	1.08E-01
CCL1	−0.09	−0.11	8.17E-02	1.11E-01
CCL2	−0.09	−0.07	9.71E-02	1.30E-01
CCL27	−0.05	−0.03	3.10E-01	3.68E-01
CCL7	−0.05	0.00	3.36E-01	3.96E-01
CXCL7	−0.05	0.07	4.00E-01	4.61E-01
CCL8	−0.04	−0.06	4.51E-01	5.13E-01
CCL14	−0.04	−0.10	4.88E-01	5.50E-01
CXCL17	−0.04	−0.10	4.90E-01	5.51E-01
CXCL9	−0.02	0.03	6.94E-01	7.40E-01
CCL16	0.01	0.06	8.38E-01	8.66E-01
CCL28	0.04	0.01	4.98E-01	5.59E-01
CXCL12	0.06	0.07	2.75E-01	3.30E-01
CXCL11	0.07	0.13	1.88E-01	2.36E-01
CXCL10	0.07	0.13	1.82E-01	2.28E-01
CCL24	0.10	0.16	5.74E-02	8.07E-02

ccRCC, clear cell renal cell carcinoma.